Frederic Jungbauer - Publications

Automated Pretreatment Thoracic CT-Based Body Composition Analysis Predicts Progression-Free Survival in Head and Neck Cancer.

Journal: Journal of clinical medicine

Published: April 07, 2026

Systemic inflammation plays a key prognostic role in patients with head and neck cancer treated with immunotherapy and is linked to CT-based body composition metrics.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: December 27, 2025

Muscle matters: automated CT-based body composition analysis predicts survival in patients with head and neck cancer treated with immunotherapy.

Journal: Frontiers in oncology

Published: October 15, 2025

Xeno-free alternatives to the use of fetal bovine serum in head and neck cancer explant culture.

Journal: Alternatives to laboratory animals : ATLA

Published: June 19, 2025

Preventing Free Flap Complications: Key Factors to Keep in Mind.

Journal: Journal of surgical oncology

Published: March 25, 2025

Real-World Outcomes of Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: Analyzing Patient-Specific Factors Influencing Survival and Response Rate.

Journal: Cancer reports (Hoboken, N.J.)

Published: February 18, 2025

Augmented Reality in head and neck surgery

Journal: Laryngo- rhino- otologie

Published: December 03, 2024

Irradiation‑induced cellular senescence is linked to pro‑survival signaling and checkpoint regulation in a 2D and 3D model for head and neck cancer.

Journal: Oncology reports

Published: November 12, 2024

C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCC.

Journal: Cancers

Published: May 17, 2024

Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: January 17, 2024

Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies - a single center study.

Journal: Frontiers in oncology

Published: September 01, 2023

Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 19, 2023